Sector Update: Health Care Stocks Declining This Afternoon
3:53PM ET 1/24/2022 MT NewswiresHealth care stocks were sliding this afternoon, with the NYSE Health Care Index falling 2.1% while the SPDR Health Care Select Sector ETF (XLV) was...
Sector Update: Health Care
3:31PM ET 1/24/2022 MT NewswiresHealth care stocks continued to sputter this afternoon, with the NYSE Health Care Index falling 2.1% and the SPDR Health Care Select Sector ETF (XLV) down...
AIkido Pharma's Board Authorizes Stock Buyback Program
2:08PM ET 1/24/2022 MT NewswiresThe board of AIkido Pharma (AIKI) authorized the company to repurchase up to $3 million of the company's common stock, effective immediately. The shares...
AIkido Pharma Gets Equity Interest in ASP Isotopes
1:48PM ET 12/06/2021 MT NewswiresAIkido Pharma (AIKI) said Monday it has secured a "strategic" equity stake in ASP Isotopes, a supplier of non-nuclear enriched isotopes, for an undisclosed...
--HC Wainwright Starts AIkido Pharma at Buy With $2 Price Target
6:47AM ET 10/11/2021 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
AIkido Pharma Acquires Equity Interest in Tevva Motors
11:04AM ET 9/28/2021 MT NewswiresAIkido Pharma (AIKI) said Tuesday it acquired an equity interest of an undisclosed size in UK-based electric truck manufacturer Tevva Motors. Tevva's core...
AIkido Acquires Stake in Tele-Health Company Kerna Health; Share Down
12:53PM ET 9/20/2021 MT NewswiresAIkido Pharma (AIKI) reported Monday that it has acquired an equity interest in tele-health company Kerna Health. Financial terms were not disclosed. Kerna...
AIkido Pharma, University of Maryland Identify Four Lead Compounds Blocking Viral Replication
11:13AM ET 7/16/2021 MT NewswiresAIkido Pharma (AIKI) and its partner, the University of Maryland, have identified four lead compounds that could inhibit the replication of multiple...
Aikido Pharma Files Provisional Patent Application for Use of Ketamine, Peptides to Treat Alzheimer's Disease
10:52AM ET 6/23/2021 MT NewswiresAikido Pharma (AIKI) said Wednesday it has filed a provisional patent application for the use of ketamine and peptides to treat Alzheimer's disease. The...
AIKido Pharma Gets Sublicense to Technology for Treatment of Neuro-Inflamed Tissue in Cancer Patients
10:07AM ET 4/07/2021 MT NewswiresAIKido Pharma (AIKI) said Wednesday it received an exclusive sublicense to technology related to the use of novel and proprietary homing peptides which can...